Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy (Q47860383)

6 February 2018

title

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy (English)

1 reference

6 February 2018

1 reference

K Sliwa

1

1 reference

6 February 2018

D Skudicky

2

1 reference

6 February 2018

G Candy

3

1 reference

6 February 2018

T Wisenbaugh

4

1 reference

6 February 2018

P Sareli

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 1998

1 reference

6 February 2018

published in

The Lancet

1 reference

6 February 2018

volume

351

1 reference

6 February 2018

issue

9109

1 reference

6 February 2018

page(s)

1091-1093

1 reference

6 February 2018

TNF-induced cardiomyopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

The cardiovascular response of normal humans to the administration of endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Oxpentifylline in endotoxaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Pentoxifylline prevents murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Successful treatment of cutaneous PAN with pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascend

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Noninvasive quantification of left ventricular wall stress. Validation of method and application to assessment of chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Cytokines and cardiac contractile function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909338-0

7 January 2021

10.1016/S0140-6736(97)09338-0

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018